Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mitsubishi Tanabe Pharma
Pharma
Astellas, Takeda, Chugai and more—Fierce Pharma Asia
Astellas CEO lays out the company's dealmaking plans. Takeda cuts jobs ahead of Trintellix patent expiry. Chugai seeks name recognition. And more.
Angus Liu
Jan 23, 2026 9:05am
China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia
Jan 9, 2026 3:00am
ALS med Radicava to change hands as Shionogi inks $2.5B buyout
Dec 22, 2025 10:10am
FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia
Dec 5, 2025 8:45am
Tanabe revs up for Bain-backed future by axing Mitsubishi name
Dec 1, 2025 11:55am
Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia
Feb 14, 2025 9:51am
